CAS 61596-53-0

formulação de pré-lipossomas 1

Descrição:

formulação de pré-lipossomas 1, identificado pelo número CAS 61596-53-0, é um tipo de sistema de entrega à base de lipídios projetado para encapsular e transportar agentes terapêuticos, particularmente em aplicações farmacêuticas. Esta formulação geralmente consiste em fosfolipídios e outros excipientes que facilitam a formação de lipossomos quando hidratados. As características dos pré-lipossomos incluem sua capacidade de aumentar a solubilidade e estabilidade de medicamentos hidrofóbicos, melhorar a biodisponibilidade e fornecer perfis de liberação controlada. Eles são frequentemente caracterizados pelo seu tamanho, que pode variar de nanômetros a micrômetros, e pela sua carga superficial, que influencia sua interação com membranas biológicas. Além disso, os pré-lipossomos podem ser adaptados para alcançar cinéticas de liberação específicas e capacidades de direcionamento, tornando-os versáteis para várias aplicações de entrega de medicamentos. A formulação é geralmente estável em condições secas e requer hidratação para formar lipossomos, que podem então encapsular ingredientes farmacêuticos ativos. No geral, os pré-lipossomos representam uma abordagem promissora no campo dos sistemas de entrega de medicamentos.

Fórmula: C₄₈H₉₆NO₈P

3,5,9-Trioxa-4-phosphanonacosan-1-aminium,4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxoeicosyl)oxy]-, inner salt,4-oxide, (7R)-

CAS: 61596-53-0

Fórmula: C₄₈H₉₆NO₈P

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 846.2515

Ref: IN-DA00IAW7

(R)-2,3-Bis(icosanoyloxy)propyl (2-(trimethylammonio)ethyl) phosphate

CAS: 61596-53-0

(R)-2,3-Bis(icosanoyloxy)propyl (2-(trimethylammonio)ethyl) phosphate

Pureza: 98%

Peso molecular: 846.27g/mol

Ref: 54-OR1067498

1,2-Diarachidoyl-sn-Glycero-3-Phosphatidylcholine

CAS: 61596-53-0

Fórmula: C48H96NO8P

Pureza: >99%

Cor e Forma: Solid

Peso molecular: 846.25

Ref: 48-37-2000

1,2-Diarachidoyl-sn-glycero-3-phosphocholine

CAS: 61596-53-0

1,2-Diarachidoyl-sn-glycero-3-phosphocholine is a polyunsaturated fatty acid that belongs to the group of phospholipids. It is found in plasma samples and has been shown to be involved in the regulation of cellular physiology. This compound has been identified as a potential marker for cardiovascular disease through its ability to reduce the risk of heart attack or stroke. The 1,2-diarachidoyl-sn-glycero-3-phosphocholine molecule contains two acyl chains, which are linked by ester bonds, and hydroxyl groups on either end of the molecule. The molecular modeling studies have revealed that this compound can exist in three conformations: bent (A), linear (B), or extended (C). In this study, it was found that conformational A was most prevalent in both hydrated and nonhydrated states.

Fórmula: C₄₈H₉₆NO₈P

Pureza: Reported

Peso molecular: 846.28 g/mol

Ref: 3D-FD172067

1,2-Diarachidoyl-sn-glycero-3-phosphocholine

CAS: 61596-53-0

1,2-Diarachidoyl-sn-glycero-3-phosphocholine (DAGPC) is a phospholipid compound that plays a crucial role in various biological processes. It acts as an interfacial agent, forming a protein complex at the cell membrane. DAGPC has been studied extensively in relation to breast cancer, cardiac health, diabetes, and other conditions. In experiments conducted on animals and human subjects, it has been shown to have potential benefits in regulating angiotensin-converting enzyme activity, supporting myocardial function, and controlling glucagon levels. Additionally, DAGPC has demonstrated promising effects in castration-induced prostate cancer models. Its unique properties make it a valuable compound for further research and potential therapeutic applications.

Fórmula: C₄₈H₉₆NO₈P

Peso molecular: 846.28 g/mol

Ref: 3D-D-1422